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Edited by Judit OvadiAbstract In primary cultured hepatocytes, fructose-1,6-bisphos-
phatase (FBPase) localization is modulated by glucose, dihy-
droxyacetone (DHA) and insulin. In the absence of these
substrates, FBPase was present in the cytoplasm, but the addition
of glucose or DHA induced its translocation to the nucleus. As
expected, we observed the opposite eﬀect of glucose on glucokinase
localization. The addition of insulin in the absence of glucose
largely increased the amount of nuclear FBPase. Moreover, at
high concentrations of glucose or DHA, FBPase shifted from the
cytosol to the cell periphery and co-localized with GS. Interest-
ingly, the synthesis of Glu-6-P and glycogen induced by DHAwas
not inhibited by insulin. These results indicate that FBPase is
involved in glycogen synthesis from gluconeogenic precursors.
Overall, these ﬁndings show that translocation may be a new
integrative mechanism for gluconeogenesis and glyconeogenesis.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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The synthesis of glucose from non-glucidic precursors, such
as lactate, amino acids and glycerol [1,2], occurs mainly in liver
and kidney and is essential for glucose homeostasis during
fasting. Fructose-1,6-bisphosphatase (FBPase, EC 3.1.3.11) is
a key enzyme in the gluconeogenic pathway as it catalyzes the
irreversible hydrolysis of fructose-1,6-bisphosphate (Fru-1,6-
P2) to fructose-6-phosphate and Pi [3]. On the basis of im-
munological and kinetic data, at least three distinct forms of
FBPase isoenzymes have been proposed: brain, muscle and
liver [3–5]. The liver isoform is the main regulatory enzyme of
gluconeogenesis in liver and kidney [1,2]; however, the physi-
ological roles of the brain and muscle isoenzymes are not fully
understood [6,7].* Corresponding author. Fax: +56-63-221407.
E-mail address: jslebe@uach.cl (J.C. Slebe).
Abbreviations: FBPase, fructose-1,6-bisphosphatase; GS, glycogen
synthase; GK, glucokinase; NLS, nuclear localization sequence; Glu-
6-P, glucose-6-phosphate; Fru-2,6-P2, fructose-2,6-bisphosphate; Fru-
1,6-P2, fructose-1,6-bisphosphate; DHA, dihidroxyacetone
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presents a homotetrameric structure (36–41 kDa per subunit)
and is regulated mainly at the posttranslational level by two
synergistic negative eﬀectors, AMP and fructose-2,6-bisphos-
phate (Fru-2,6-P2) [8,9]. These metabolites play a crucial
function by modulating the rate of gluconeogenic/glycolytic
ﬂuxes. Although the liver isoform is found in various human
and rat tissues [10], it is expressed mainly in liver and kidney, bi-
functional organs that perform glycolysis and gluconeogenesis.
In addition, FBPase exhibits a cellular compartmentation in
these two tissues, with almost exclusive expression in kidney
proximal tubules and higher expression levels in periportal
hepatocytes than the perivenous region [11]. In these tissues,
FBPase also shows a particular subcellular distribution. In
kidney, it is distributed throughout the cytoplasm and in an
apical peripheral compartment of proximal epithelial cells.
Similar results are observed in liver, where the enzyme is mainly
localized in the cytoplasm of periportal hepatocytes, and in a
speciﬁc compartment close to the plasma membrane of adja-
cent hepatocytes [11]. Interestingly, FBPase is also observed in
the nuclei of hepatocytes and proximal epithelial cells.
The subcellular redistribution of some metabolic enzymes is
dynamic and responsive to metabolic conditions. In the ab-
sence of glucose, Glucokinase (GK) is bound to its regulatory
protein in the nucleus of the hepatocyte and translocates to the
cytoplasm when sugar levels increase [12]. Muscle glycogen
synthase (GS) is also concentrated in the nucleus at low glu-
cose and translocates to the cytosol, where it adopts a partic-
ulate pattern at high glucose concentrations [13,14]. In
contrast, liver GS presents a cytosolic distribution in the ab-
sence of glucose and concentrates at the periphery of the he-
patocytes when the hexose concentration increases [15].
Here, we examined the subcellular distribution of FBPase in
comparison with GK and GS localization in primary cultured
hepatocytes. Our results indicate that the subcellular location
of FBPase is modulated by the action of glucose, dihydroxy-
acetone (DHA) and insulin.2. Materials and methods
2.1. Hepatocyte isolation and culture
Fasted male rats weighing 300 g were used. Hepatocytes were iso-
lated by liver perfusion with collagenase (Sigma) as described [16].
Cells were suspended in 50 ml of Dulbecco’s modiﬁed Eagle’s mediumation of European Biochemical Societies.
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fetal bovine serum (FBS; Sigma), 100 nM insulin (Sigma), 100 nM
dexamethasone (Sigma) and 1% (v/v) penicillin/streptomycin (Invit-
rogen), and seeded onto gelatin-coated coverslips placed in 24-well
plates. After 5 h incubation at 37 C in humidiﬁed air/CO2 (19:1)
chamber, cells were washed with sterile PBS and the culture medium
was replaced with glucose-free DMEM including 10% FBS. After
overnight incubation, the hepatocytes were incubated for 6 h in one of
the following DMEM conditions: (1) glucose-free, (2) 25 mM glucose,
(3) glucose-free supplemented with 10 mM DHA (Sigma), (4) glucose-
free + 10 nM insulin, and (5) 25 mM glucose + 10 nM insulin (Sigma).
The hepatocytes were then ﬁxed for immunohistochemistry and cell
monolayers were scraped to prepare total cell extracts.
2.2. Antibodies
Rabbit antiserum against puriﬁed pig FBPase was used [11]. FBPase
was puriﬁed from pig kidney as described by Reyes et al. [17]. Chicken
egg yolk antibodies against FBPase were prepared by immunizing two
Leghorn hens through two subcutaneous injections of an emulsiﬁed
mixture of puriﬁed proteins (2 mg) with Freund’s complete adjuvant
(ﬁrst injection) or incomplete adjuvant (second injection) at 2-week
intervals. Two weeks after the second injection, a booster of 4 mg of
pure enzymes was given. The eggs were collected daily throughout the
study period and stored at 4 C until analysis. The isolation of poly-
clonal IgY from egg yolk granules was performed following the
method described by Akita and Nakai [18]. GS antibody was raised in
rabbit against a peptide that contains the fourteen C-terminal amino
acids of rat liver GS. This antiserum has a high speciﬁcity for liver GS
and does not cross-react with the muscle isoform [15]. The anti-rat liver
GK antibody was raised in rabbit [12].
2.3. Immunoﬂuorescence analysis
The analysis was performed in three (n ¼ 3) independent experiments.
Hepatocytes seeded onto gelatin-coated coverslips were washed with
PBS and ﬁxed with 4% (w/v) paraformaldehyde (Polysciences, Inc.) in
PBS for 20min. The cells were then treatedwith 1mg/mlNaBH4 (Sigma)
in PBS permeabilized with 0.3% (v/v) Triton X-100 (Sigma) in PBS and
blocked with 3% (w/v) BSA (Calbiochem) in PBS. The samples were
dually incubated for 2 h at room temperature with primary antibodies
against FBPase and GS or FBPase and GK, respectively, diluted in 1%
BSA in PBS. Cells were then washed with PBS and incubated for 1 h at
room temperature with Alexa Fluor 594 and Alexa Fluor 488-conju-
gated secondary antibodies against rabbit IgG and chicken IgY (Mo-
lecular Probes, Eugene, OR) respectively. Finally, the hepatocytes were
washed again with PBS and mounted onto microscope glass slides with
Fluorescent Mounting Medium (DAKO Corporation, Carpinteria,
CA). Optical sections of 1 lm were obtained using a Zeiss (Jena, Ger-
many) LSM5 Pascal Laser scanning confocal microscope at the Centro
de Estudios Cientıﬁcos-Valdivia (CECS). Alexa Fluor 594 and Alexa
Fluor 488 ﬂuorescence were excited at 568 and 488 nm, respectively.
2.4. Metabolite determinations
To measure glycogen content, cell monolayers were scraped into
30% KOH, the extract was then boiled for 15 min and centrifuged at
5000 g for 15 min. Glycogen was measured in the cleared superna-
tants as described [19]. The intracellular concentration of glucose-6-
phosphate (Glu-6-P) was measured using a spectrophotometric assay.
Glucose concentration in the incubation medium was measured as
described [19]. The metabolites were measured in three independent
experiments (n ¼ 3).Table 1
Hepatocytes were maintained for 16 h in a medium devoid of glucose
and DHA and then incubated for 6 h with glucose or DHA in the
absence or presence of 10 nM insulin (n ¼ 3)
Glycogen
(lg/mg protein)
Glu-6-P
(nmol/mg protein)
No substrates 3.80 0.2 0.25 0.03
25 mM glucose 31.8 1.8 3.1 0.14
10 mM DHA 30.0 2.0 5.5 0.2
No substrates + insulin 7.91 0.5 0.15 0.03
25 mM glucose + insulin 39.2 1.9 4.2 0.15
10 mM DHA + insulin 33.5 1.5 5.2 0.2
The total intracellular content of glycogen and Glu-6-P was measured3. Results
We studied the eﬀect of glucose and DHA (substrates) and
insulin on the intracellular distribution of liver FBPase by
immunoﬂuorescence and confocal analysis in cultured rat he-
patocytes. We concomitantly analyzed the subcellular distri-
bution patterns of GK and GS and compared them with that
of FBPase. In addition, we evaluated the eﬀect of glucose,
DHA and insulin on the intracellular Glu-6-P concentration
and glycogen content. Hepatocytes were maintained for 16 h ina medium devoid of substrates and then incubated for 6 h with
25 mM glucose or 10 mM DHA in the absence or presence of
10 nM insulin. In the hepatocytes incubated in the absence of
substrates, the level of glycogen and Glu-6-P was very low
(Table 1). In this condition, FBPase was observed in the cy-
toplasm of the hepatocytes, showing a strong immunostaining
in the cell periphery around the group of the cells. Low im-
munoreaction was detected in the nuclei (Fig. 1B and H).
When the cells were incubated with 25 mM glucose, the en-
zyme changed its subcellular localization and concentrated
within the nucleus (Fig. 2E and K). As previously reported,
GK was present in the nucleus in the absence of glucose and
translocated to the cytosol in the presence of the sugar, and
showed a visible juxtanuclear localization (Fig. 1A and D).
Detailed co-localization analysis of FBPase with GK showed
that these two enzymes translocated in opposite directions in
response to glucose (Fig. 1A and D, respectively). Addition-
ally, in response to high glucose concentration, FBPase was
recruited to the cell periphery (Fig. 1D–F and J–L). As pre-
viously described, GS changed its cellular distribution from a
uniform cytoplasmatic distribution to an accumulation at the
cell periphery (Fig. 1G and J), where it showed a high degree of
co-localization with FBPase (Fig. 1J–L). In the hepatocytes
incubated with 25 mM glucose, there was an 8- and 12-fold
increase in the intracellular concentration of glycogen and
Glu-6-P, respectively, when compared with those incubated in
the absence of substrates (Table 1).
DHA is an eﬀective gluconeogenic substrate, thus we ana-
lyzed its eﬀect on the intracellular distribution of FBPase.
DHA (10 mM) induced the same pattern of FBPase and GS
localization as glucose. DHA stimulus produced the recruit-
ment of the two enzymes in peripheral compartments of the
hepatocytes. Moreover, DHA induced FBPase translocation
into the nucleus, but to a lesser extent than that produced by
glucose. By contrast, this gluconeogenic precursor was unable
to elicit any change in GK subcellular distribution and the
enzyme remained in the nucleus (data not shown). Incubation
with this substrate led to a marked increase in Glu-6-P levels,
which were about 22-fold higher than in control cells (Table 1).
Under these conditions, the hepatocytes produced the same
amount of glycogen as those incubated with 25 mM glucose
(Table 1).
We next analyzed the eﬀect of insulin in the absence and in
the presence of glucose. In hepatocytes incubated with 10 nM
insulin in the absence of glucose, FBPase translocated largely
into the nucleus (Fig. 2D–F), although it presented a less sig-
niﬁcant peripheral distribution than that observed when cells
were incubated with glucose alone. In this condition, there was.
Fig. 1. Subcellular distribution of FBPase, GS and GK in hepatocytes cultured with 25 mM glucose or 10 mM dihydroxyacetone. Cultured he-
patocytes treated diﬀerentially were ﬁxed and co-incubated with rabbit anti-GK and chicken anti-FBPase (A–F) and with rabbit anti-GS and chicken
anti-FBPase (G–O). The enzymes were detected using Alexa Fluor 594-labeled anti-rabbit IgG (red label) and Alexa Fluor 488-labeled anti-chicken
IgY (green label) as secondary antibodies. The images C, F, I, L and O correspond to the merging images, respectively. Scale bar 20 lm.
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bated with 10 nM insulin plus 25 mM glucose, FBPase showed
a similar accumulation at the cell periphery but was clearly
more concentrated in the nucleus of the hepatocytes than when
incubated with glucose alone (Fig. 2G–L). The same distri-
bution pattern was observed in hepatocytes co-incubated with
10 mM DHA and 10 nM insulin (data not shown). Insulin
alone produced a limited eﬀect on GS distribution; neverthe-
less, this hormone potentiated the glucose-induced recruitment
of GS towards the cell periphery (Fig. 2G and J). Interestingly,
hepatocytes co-incubated with 10 mM DHA and 10 nM in-
sulin used this substrate in the gluconeogenic production of
Glu-6-P and glycogen.4. Discussion
The subcellular organization and metabolite modulation of
gluconeogenic enzymes are poorly understood. Here, we show
for the ﬁrst time that the subcellular localization of the liver
isoenzyme of rat FBPase is modulated by the metabolic con-
ditions of the cultured hepatocytes. These ﬁndings suggest that
the modulation of the subcellular location of this enzyme may
be a new regulatory mechanism of the gluconeogenic pathway.
In response to an increase in glucose or DHA concentration,
FBPase showed nuclear import and recruitment in a peripheral
cell compartment. Interestingly, FBPase and GS were co-
recruited to the periphery of the cells. This is precisely the site
Fig. 2. Subcellular distribution of FBPase and GS in hepatocytes cultured with 10 nM insulin in the absence or in the presence of 25 mM glucose.
Cultured hepatocytes treated diﬀerentially were ﬁxed and co-incubated with rabbit anti-GS and chicken anti-FBPase. The enzymes were detected
using Alexa Fluor 594-labeled anti-rabbit IgG (red label) and Alexa Fluor 488-labeled anti-chicken IgY (green label), as secondary antibodies. The
images C, F, I and L correspond to the merging images. Scale bar 20 lm.
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polysaccharide grow from the periphery of the hepatocytes
towards the interior [15]. This ﬁnding supports the notion of
the formation of a complex between FBPase and the glycogen
synthesis enzymes. This complex may allow the channeling of
substrates and the enhancement of glycogen synthesis. In this
context, the importance of the compartmentation of enzymes
and the concomitant channeling of substrates has been dis-
cussed by Ovadi and Srere [20,21]. This micro-compartmen-
tation, together with other factors involved in channeling,
provides many potential biological advantages, such as the
isolation of intermediates from competing reactions and a new
means of metabolic regulation by modulating enzyme associ-
ations, which ensure the proper function and integration of
metabolic pathways [20,21]. We observed similar capacities of
glucose and DHA to stimulate the redistribution of FBPase
and GS to the cell periphery. This result indicates that the
direct pathway of glycogen synthesis from glucose and the
indirect pathway from gluconeogenic precursors are located in
the same subcellular functional compartment. By contrast,
DHA has no eﬀect on the subcellular localization of GK (datanot shown). We measured Glu-6-P as an intermediate pre-
cursor of glycogen synthesis, and as previously reported [19],
we found that part of the Glu-6-P produced by gluconeogen-
esis from DHA was channeled to glycogen deposition.
Moreover, the colocalization of FBPase with GS was not
inhibited by the action of insulin. This hormone stimulates
glycogen synthesis, inhibits glycogen breakdown, and sup-
presses gluconeogenesis [22]. However, our data reveal that the
synthesis of Glu-6-P and glycogen induced by DHA was not
inhibited by insulin. These results show that the major eﬀect of
insulin is on neither Glu-6-P synthesis nor on the synthesis of
glycogen, indicating that under these conditions the indirect
pathway of glyconeogenesis is active in hepatocytes. These
results are consistent with current data that demonstrate that
liver glycogenolysis is acutely sensitive to small changes in
plasma insulin, whereas gluconeogenic ﬂux is not [23]. On the
basis of the observation of the recruitment of FBPase and GS
in the cell periphery induced by high glucose, we hypothesize
that, even in this condition, FBPase participates in glycogen
synthesis. This notion is also supported by studies which show
that the postprandial synthesis of glycogen is dramatically
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speciﬁc inhibitors [24,25]. Glucose utilization raises Glu-6-P
and glycogen in hepatocytes, but also induces the increase of
gluconeogenic/glycolytic intermediates. Thus, the recruitment
and binding of FBPase to the GS compartment may prevent
the inhibition of FBPase by the allosteric eﬀector (AMP),
thereby allowing the recycling and channeling of glycolytic
intermediates to glycogen. Studies by Dzugaj’s laboratory
support this hypothesis and demonstrate that FBPase in a
complex with aldolase is insensitive to AMP inhibition [26].
Furthermore, we found that insulin strongly induced a
reversible FBPase translocation into the nucleus. This result
conﬁrms our previous data that showed the capacity of liver
FBPase to translocate into the nuclei of hepatocytes and
reveals, for the ﬁrst time, a hormonal regulation mechanism
for the nuclear localization of a gluconeogenic enzyme
[11,27]. The entry of proteins of a size greater than the
exclusion limit of the nuclear pore complex depends on the
presence of a nuclear localization signal (NLS) sequence
within the protein. In the absence of this sequence, large
proteins enter the nucleus via interactions with other pro-
teins by a piggy-back mechanism. Rat liver FBPase is an
homotetrameric enzyme of approximately 155 KDa, whereas
the exclusion limit of the nuclear pore permits only the
passive diﬀusion of proteins of less than 45 KDa [28].
Similarly, the export of proteins from the nucleus is an ac-
tive process that depends on a distinct motif called a nuclear
export signal (NES) sequence. Using neural networks that
predict subcellular localization, we found that liver FBPase
contains a classical NLS [11,29,30]. Nevertheless, we cannot
rule out a piggy-back mechanism to explain FBPase nuclear
import.
Glucose-induced nuclear translocation of several enzymes,
including GK, glyceraldehyde-3-phosphate dehydrogenase
(GAPDH), muscle GS, aldolase, lactate dehydrogenase (LDH)
and phosphoglycerate kinase (PGK) is a well-known phe-
nomenon. Additional functions have been proposed for these
enzymes in the nuclei. Of particular interest are their putative
roles in gene transcription, nuclear stabilization, DNA repair
and DNA synthesis [13,31–34]. Recently, we proposed distinct
roles for FBPase in the nuclei of liver and kidney cells [11];
however, we cannot rule out that the function of nuclear
FBPase is to produce Glu-6-P. This nuclear pool of Glu-6-P
may generate the NADPH required for the generation of re-
duced glutathione, which exerts essential antioxidant and de-
toxifying functions for the maintenance of key protein thiol
groups [32,35].
In conclusion, this is the ﬁrst report that shows the capacity
of glucose and insulin to induce the nuclear translocation of a
gluconeogenic enzyme. Considering the broad metabolic
function of hepatocytes, the present study reveals a further
sophistication of the regulatory mechanism that controls the
glucose pathways, and the integration of gluconeogenesis and
glyconeogenesis in hepatocytes.
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